Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

Taking their lead from their summer counterparts, Australia's 2026 Winter team are set to be remembered as the most ...

From all-core and no arms to ski jumping into pools because there’s no snow, Australian Olympians have unusual (but effective) training.

CORTINA D’AMPEZZO, Italy (AP) — Ilia Malinin's coronation as an Olympic champion will have to wait. The 21-year-old U.S. figure skater stumbled twice during an uncharacteristically sloppy performance ...

On the first day of summer break for New York City public school students, city pools are officially open. Mayor Eric Adams and other city officials kicked off the pool season by attending the ...

APOPKA, Fla. – You may have heard about protecting the Ps when it’s freezing. Those are people, plants, pets and pipes. So let’s talk about pool pipes and what that means in Florida. When the ...

Aussie Bree Walker finished second behind German Laura Nolte in the season-long overall monobob standings. Walker beat Nolte in the final event of the season but could not quite overcome her lead.

Cleaning a swimming pool ranks right up there with scrubbing bathroom floors, but the consequences of neglecting either chore are equally unhealthy. Fortunately, living in the age of robots means you ...

A drug for autoimmune disease Sjögren's syndrome, picked up by Novartis when it bought MorphoSys for $2.9 billion last year, has hit the target in a pair of phase 3 trials. Ianalumab (VAY736), a drug ...

A backyard pool is a great way to relax alone or socialize with friends and family, but they do require some work to keep them clean. Whether you have an in- or above-ground pool, a reliable and ...

Otsuka has claimed FDA approval for its IgA nephropathy (IgAN) therapy Voyxact, joining an increasingly crowded market and beating rival Vera Therapeutics to the punch. Anti-APRIL antibody Voyxact ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...